Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"

Last updated: September 18, 2025
Sponsor: Vivent Health
Overall Status: Completed

Phase

4

Condition

N/A

Treatment

Descovy

Clinical Study ID

NCT05528653
IN-US-412-6419
  • Ages > 18
  • Male
  • Accepts Healthy Volunteers

Study Summary

To evaluate if utilizing Telehealth medicine for access to HIV PrEP will engage more Black and Latino Men who have sex with Men (MSM)

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. HIV negative on any FDA approved HIV test within 10 days of starting PrEP 18 yearsand older

  2. No medical or mental health comorbidity that would preclude participating in aclinical study as deemed by the study investigator

  3. Able to understand and sign consent in English or with other language interpreter

  4. Able to stay in the state catchment area of the license health care provider

  5. No use of PrEP for more than 30 days in the last year

Exclusion

Exclusion Criteria:

  1. HIV positive

  2. If greater and equal to 50 years of age and Renal Glomerular Filtration Rate (GFR) <30 mg/g

  3. <18 years of age

  4. No access to Internet or devise for telehealth

  5. Cis-gender Women

Study Design

Total Participants: 75
Treatment Group(s): 1
Primary Treatment: Descovy
Phase: 4
Study Start date:
July 19, 2022
Estimated Completion Date:
March 21, 2025

Study Description

The goal of this study is to determine whether incorporating a telehealth model that allows for same-day appointments for PrEP delivery with the support of navigation leads to increased uptake and persistence of PrEP in young MSM/transgender of color and individuals in rural communities that have disproportionately not used PrEP. The investigators will accomplish this by using an effectiveness-hybrid design that will allow us to both evaluate the interventions impact on relevant clinical outcomes as well as the effectiveness of the implementation strategy. Our hypothesis is that by removing some of the barriers to care such as transportation, childcare, work schedule and potentially stigma with repeated clinic visits, the investigators will increase the uptake and persistence of PrEP amongst communities who historically have had many barriers to care and have not started PrEP.

Connect with a study center

  • Vivent Health

    Denver, Colorado 80245
    United States

    Site Not Available

  • Vivent Health

    Denver 5419384, Colorado 5417618 80245
    United States

    Site Not Available

  • Vivent Health

    Saint Louis, Missouri 63103
    United States

    Site Not Available

  • Vivent Health

    St Louis 4407066, Missouri 4398678 63103
    United States

    Site Not Available

  • Viventh Health

    Milwaukee, Wisconsin 53203
    United States

    Site Not Available

  • Viventh Health

    Milwaukee 5263045, Wisconsin 5279468 53203
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.